| 000 | 01747cab a2200289Ia 45 0 | ||
|---|---|---|---|
| 001 | u203056 | ||
| 003 | SIRSI | ||
| 008 | 121108s2011 ua ss b eng d | ||
| 040 | _aEAL | ||
| 041 | _aengbara | ||
| 090 | _aART ZVJ V39 NO3 18 | ||
| 100 | 1 | _aMohmad, M. A. | |
| 240 | 1 | 0 |
_aZagazig veterinary journal, 2011 v. 39 (3) _h[electronic resource]. |
| 245 | 1 | 0 |
_aPharmacokinetic evaluation of cefotaxime after intramuscular administration in chickens _h[electronic resource]. |
| 246 | 1 | 5 | _aتقييم الحركة الدوائية للسيفوتاكسيم بعد الحقن العضلى فى الدجاج. |
| 300 | _ap.155-159. | ||
| 504 | _aIncludes references. | ||
| 520 | _aPhannacokinetics of cefotaxime was investigated in clinically healthy chickens following single intramuscular injection of three doses (5, 10 and 20 mglkg.bwt.). An increase in concentration of the drug was found with increasing dose at all the sampling times in each subject. The peak serum concentrations (Cmax) of cefotaxime was 4.5, 8.0 and 21.60Jlglml at maximum time at which the drug reach maximum concentration (tmax) of 28, 29 and 30 minutes, respectively. The serum concentrations was decreased with elimination half lives (lO.5e) of 0.72 ,0.70 and 0.71 hours and The area under serum drug concentration (AUCo-oo) was 7.09, 12.32 and 32.58 Jlg.mP.h for the three doses, respectively. | ||
| 546 | _aSummary in Arabic. | ||
| 650 | 0 | _aPharmacokinetics. | |
| 650 | 0 |
_aCefotaxime _xPharmacokinetics |
|
| 650 | 0 | _aEscherichia coli infections. | |
| 700 | 1 | _aGehan, NA | |
| 773 | 0 |
_tZagazig Veterinary Journal. _g2011.v.39(3) _x1110-1458 _7nass _wu189860 |
|
| 856 | 4 | 0 |
_uhttp://nile.enal.sci.eg/EALE/2011/ZVJ/3911/3/155.pdf _zFull Text Article. |
| 596 | _a1 | ||
| 942 |
_cAR _2lcc |
||
| 999 |
_c54858 _d54858 |
||